Identifiants chercheur

Nombre de documents

15

CV


Article dans une revue15 documents

  • Lionel Berthoin, Bertrand Toussaint, Frédéric Garban, Audrey Le Gouellec, Benjamin Caulier, et al.. Targeted release of transcription factors for cell reprogramming by a natural micro-syringe.. International Journal of Pharmaceutics, Elsevier, 2016, pp.678-687. <hal-01464092>
  • Xavier Chauchet, Dalil Hannani, Sophia Djebali, David Laurin, Benoit Polack, et al.. Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.. Molecular therapy oncolytics, 2016, pp.16033. <hal-01463683>
  • Perrine Bortolotti, Benjamin Hennart, Camille Thieffry, Guillaume Jausions, Emmanuel Faure, et al.. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.. BMC Microbiology, BioMed Central, 2016, pp.137. <hal-01464093>
  • Charlotte Genestet, Audrey Le Gouellec, Hichem Chaker, Benoit Polack, Benoit Guery, et al.. Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.. Advances in Free Radical Biology & Medicine, Elsevier, 2014, pp.400-10. <hal-01464090>
  • Yan Wang, Bertrand Toussaint, Audrey Le Gouëllec. Bacterial vectors for the delivery of tumor antigens.. Methods in Molecular Biology -Clifton then Totowa-, Humana Press (Springer Imprint), 2014, 1139, pp.429-41. <10.1007/978-1-4939-0345-0_33>. <hal-00979502>
  • Audrey Le Gouëllec, Xavier Chauchet, David Laurin, Caroline Aspord, Julien Verove, et al.. A Safe Bacterial Microsyringe for In Vivo Antigen Delivery and Immunotherapy. Molecular Therapy, Nature Publishing Group, 2013, 21 (5), pp.1076-1086. <10.1038/mt.2013.41>. <hal-00813378>
  • Bertrand Toussaint, Xavier Chauchet, Yan Wang, Benoit Polack, Audrey Le Gouëllec. Live-attenuated bacteria as a cancer vaccine vector.. Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2013, 12 (10), pp.1139-54. <10.1586/14760584.2013.836914>. <hal-00918311>
  • Audrey Le Gouellec, Xavier Chauchet, Benoit Polack, Laurent Buffat, Bertrand Toussaint. Bacterial vectors for active immunotherapy reach clinical and industrial stages.. Human Vaccines, Taylor & Francis, 2012, 8 (10), pp.1454-8. <10.4161/hv.21429>. <hal-00813376>
  • Yan Wang, Audrey Le Gouëllec, Hichem Chaker, Hoda Asrih, Benoit Polack, et al.. Optimization of antitumor immunotherapy mediated by type III secretion system-based live attenuated bacterial vectors.. Journal of immunotherapy : official journal of the Society for Biological Therapy, Raven Press Publishers, 2012, 35 (3), pp.223-34. <10.1097/CJI.0b013e31824747e5>. <hal-00849581>
  • Madiha Derouazi, Yan Wang, Raphaël Marlu, Olivier Epaulard, Jean-François Mayol, et al.. Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.. Bioeng Bugs, 2010, 1 (1), pp.51-60. <10.4161/bbug.1.1.9482>. <hal-00813353>
  • Soizic Masson, Thomas Kern, Audrey Le Gouëllec, Cécile Giustini, Jean-Pierre Simorre, et al.. Central domain of DivIB caps the C-terminal regions of the FtsL/DivIC coiled-coil rod.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2009, pp.27687-700. <hal-01464089>
  • Audrey Le Gouëllec, Laure Roux, Daniela Fadda, Orietta Massidda, Thierry Vernet, et al.. Roles of pneumococcal DivIB in cell division.. Journal of Bacteriology, American Society for Microbiology, 2008, pp.4501-11. <hal-01464088>
  • Cécile Morlot, Lucile Pernot, Audrey Le Gouellec, Anne-Marie Di Guilmi, Thierry Vernet, et al.. Crystal structure of a peptidoglycan synthesis regulatory factor (PBP3) from Streptococcus pneumoniae.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2005, pp.15984-91. <hal-01464084>
  • Marjolaine Noirclerc-Savoye, Audrey Le Gouëllec, Cécile Morlot, Otto Dideberg, Thierry Vernet, et al.. In vitro reconstitution of a trimeric complex of DivIB, DivIC and FtsL, and their transient co-localization at the division site in Streptococcus pneumoniae.. Molecular Microbiology, Wiley, 2004, pp.413-24. <hal-01464086>
  • Lucile Pernot, Laurent Chesnel, Audrey Le Gouellec, Jacques Croizé, Thierry Vernet, et al.. A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics.. Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2004, pp.16463-70. <10.1074/jbc.M313492200>. <hal-01464081>